Octaplas 11.5 g/200mL
human plasma proteins · SOLUTION · Octapharma USA Inc
Octaplas is a solution containing human plasma proteins at 11.5 g/200mL, taken intravenous. Manufactured by Octapharma USA Inc.
Key Facts
- Brand Name
- Octaplas
- Generic Name
- human plasma proteins
- NDC Code (Product)
68982-952- Manufacturer
- Octapharma USA Inc
- Strength
- 11.5 g/200mL
- Dosage Form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125416
- Marketing Start
- 07/18/2013
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
USES: Assists in support of the pancreas.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Dosage & Administration
DIRECTIONS: • Adults: 2 to 3 sprays orally, three times daily. Children under twelve one half adult dosage. • Do not take within 15 minutes of consuming food, beverage or brushing teeth. • Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS: If pregnant or breast-feeding, ask a health professional before use. In case of overdose, get medical help or contact a Poison Control Center right away. If condition worsens, seek medical attention. KEEP OUT OF REACH OF CHILDREN Do not use if tamper evident seal is broken or missing. Store in a cool place after opening
Frequently Asked Questions
What is Octaplas used for?
Octaplas contains human plasma proteins. It is a solution taken intravenous. Consult your doctor for specific uses.
Is Octaplas a controlled substance?
Octaplas is not classified as a controlled substance by the DEA.
What is the generic name for Octaplas?
The generic name for Octaplas is human plasma proteins. There are no other listed brand versions of human plasma proteins.
What is the NDC code for Octaplas 11.5 g/200mL?
The NDC (National Drug Code) for Octaplas 11.5 g/200mL is 68982-952, listed by Octapharma USA Inc.
Other Octaplas Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)